Avivagen Valuation
| VIVXF Stock | USD 0.0001 0.00 0.00% |
Avivagen seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Avivagen from analyzing the firm fundamentals such as Shares Owned By Insiders of 1.43 %, current valuation of 9.01 M, and Return On Asset of -0.95 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Avivagen's price fluctuation is out of control at this time. Calculation of the real value of Avivagen is based on 3 months time horizon. Increasing Avivagen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Avivagen pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Avivagen. Since Avivagen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avivagen Pink Sheet. However, Avivagen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 9.6E-5 | Hype 6.0E-5 |
The real value of Avivagen Pink Sheet, also known as its intrinsic value, is the underlying worth of Avivagen Company, which is reflected in its stock price. It is based on Avivagen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Avivagen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Avivagen helps investors to forecast how Avivagen pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avivagen more accurately as focusing exclusively on Avivagen's fundamentals will not take into account other important factors: Avivagen Total Value Analysis
Avivagen is at this time anticipated to have takeover price of 9.01 M with market capitalization of 5.2 M, debt of 1.4 M, and cash on hands of 494.81 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Avivagen fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.01 M | 5.2 M | 1.4 M | 494.81 K |
Avivagen Investor Information
The company recorded a loss per share of 0.08. Avivagen last dividend was issued on the 25th of May 2017. The entity had 1:10 split on the 25th of May 2017. Based on the analysis of Avivagen's profitability, liquidity, and operating efficiency, Avivagen is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Avivagen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Avivagen has an asset utilization ratio of 37.26 percent. This implies that the Company is making $0.37 for each dollar of assets. An increasing asset utilization means that Avivagen is more efficient with each dollar of assets it utilizes for everyday operations.Avivagen Ownership Allocation
Avivagen holds a total of 77.19 Million outstanding shares. Almost 98.57 percent of Avivagen outstanding shares are held by general public with 1.43 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Avivagen Profitability Analysis
The company reported the revenue of 1.3 M. Net Loss for the year was (6.39 M) with profit before overhead, payroll, taxes, and interest of 534.34 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Avivagen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Avivagen and how it compares across the competition.
About Avivagen Valuation
The pink sheet valuation mechanism determines Avivagen's current worth on a weekly basis. Our valuation model uses a comparative analysis of Avivagen. We calculate exposure to Avivagen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avivagen's related companies.Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada. Avivagen is traded on OTC Exchange in the United States.
8 Steps to conduct Avivagen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Avivagen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Avivagen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Avivagen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Avivagen's revenue streams: Identify Avivagen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Avivagen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Avivagen's growth potential: Evaluate Avivagen's management, business model, and growth potential.
- Determine Avivagen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Avivagen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Avivagen Growth Indicators
Investing in growth stocks can be very risky. If the company such as Avivagen does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 57 M | |
| Retained Earnings | -40.5 M |
Complementary Tools for Avivagen Pink Sheet analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |